NEWS RELEASE 
March 21, 2019

BACTERIA IN URINE DOESN’T ALWAYS INDICATE INFECTION
Testing, Antibiotic Treatment Often Unnecessary, Say IDSA Guidelines

 

AT A GLANCE Most patients shouldn’t be tested for a urinary tract infection (UTI) unless they have symptoms, according to updated asymptomatic bacteriuria (ASB) guidelines released by IDSA. ASB – the presence of bacteria in the urine without the symptoms of an infection – shouldn’t be treated with antibiotics except in certain patients such as those having urologic surgery and pregnant women. Misuse of antibiotics adds to the growing problem of antibiotic resistance. The guidelines note children, people having non-urologic surgery, healthy non-pregnant women and the elderly are among those who often are tested but should not be unless they have symptoms of a UTI (such as frequent urination or burning).

Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

ASB – the presence of bacteria in the urine without the symptoms of an infection – is quite common and has been identified as a contributor to antibiotic misuse, which promotes resistance. While the updated guidelines follow previous recommendations to avoid testing certain groups of patients who don’t have symptoms (called screening) – including healthy non-pregnant women, the elderly, people with diabetes and those with spinal cord injuries – they also include groups that weren’t previously addressed, such as infants and children, people who have had joint replacement or other non-urologic surgery and those who have had organ transplants.

“Screening these patients is far too common and leads to the inappropriate prescribing of antibiotics, which some studies suggest may actually increase the risk of a UTI, as well as contribute to other serious infections such as Clostridioides difficile,” said Lindsay E. Nicolle, MD, FIDSA, chair of the committee that developed the guidelines and professor emeritus at the Rady Faculty of Health Sciences at the University of Manitoba, Winnipeg. “Generally, physicians should not obtain urine cultures unless patients have symptoms consistent with an infection, such as burning during urination, frequent urination or abdominal pain or tenderness on the back near the lower ribs.”

Some symptoms that people assume indicate a UTI – such as urine odor and confusion in the elderly – are usually caused by other conditions that should be ruled out before testing, Dr. Nicolle said.

About 3 to 7 percent of healthy women have ASB at any given time, especially those who are sexually active, she said. About 50 percent of people with spinal injuries and 30 to 50 percent of people in nursing homes have ASB.

The updated guidelines follow previous guideline recommendations to screen and treat only patients who are at risk of developing complications of ASB, including pregnant women and those undergoing endoscopic urologic procedures.

In addition to Dr. Nicolle, the guidelines panel includes Kalpana Gupta, MD, Suzanne F. Bradley, MD, FIDSA, Richard Colgan, MD, Gregory P. DeMuri, MD, Dimitri Drekonja, MD, MS, FIDSA, Linda O. Eckert, MD, Suzanne E. Geerlings, MD, Bela Koves, MD, Thomas M. Hooton, MD, FIDSA, Manisha Juthani-Mehta, MD, FIDSA, Shandra L. Knight, MA, Sanjay Saint, MD, FIDSA, Anthony J. Schaeffer, MD, Barbara Trautner, MD, FIDSA, Bjorn Wullt, MD and Reed Siemieniuk, MD, PhD.

IDSA has published more than 50 treatment guidelines on various conditions and infections, ranging from HIV/AIDS to skin and soft tissue infections. As with other IDSA guidelines, the ASB guidelines will be available in a smartphone format and a pocket-sized quick-reference edition.

Note: For a copy of the ASB guidelines released March 21, 2019, please contact Samantha Guckenberger at (312) 558-1770 or sguckenberger@pcipr.com.

# # #

The Infectious Diseases Society of America (IDSA), based in Arlington, Va., is a professional society representing more than 11,000 physicians and scientists who specialize in infectious diseases. For more information, visit www.idsociety.org. Follow IDSA on Facebook and Twitter.

Clinical Infectious Diseases is a leading journal in the field of infectious diseases with a broad international readership. The journal publishes articles on a variety of subjects of interest to practitioners and researchers. Topics range from clinical descriptions of infections, public health, microbiology, and immunology to the prevention of infection, the evaluation of current and novel treatments, and the promotion of optimal practices for diagnosis and treatment. The journal publishes original research, editorial commentaries, review articles, and practice guidelines and is among the most highly cited journals in the field of infectious diseases. Clinical Infectious Diseases is an official publication of the Infectious Diseases Society of America (IDSA).